BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17275886)

  • 1. Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers.
    Kalani M; Silveira A; Blombäck M; Apelqvist J; Eliasson B; Eriksson JW; Fagrell B; Torffvit O; Hamsten A; Jörneskog G
    Thromb Res; 2007; 120(5):653-61. PubMed ID: 17275886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease.
    Edvinsson LI; Edvinsson ML; Angus Deveber G
    Int Angiol; 2003 Jun; 22(2):141-7. PubMed ID: 12865879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of three months of low molecular weight heparin (dalteparin) treatment after bypass surgery for lower limb ischemia--a randomised placebo-controlled double blind multicentre trial.
    Jivegård L; Drott C; Gelin J; Groth O; Hensäter M; Jensen N; Johansson G; Konrad P; Lindberg B; Lindhagen A; Lundqvist B; Oden A; Smith L; Stenberg B; Thornell E; Wingren U; Ortenwall P
    Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):190-8. PubMed ID: 15649728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight heparin seems to improve local capillary circulation and healing of chronic foot ulcers in diabetic patients.
    Jörneskog G; Brismar K; Fagrell B
    Vasa; 1993; 22(2):137-42. PubMed ID: 8391741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study.
    Kalani M; Apelqvist J; Blombäck M; Brismar K; Eliasson B; Eriksson JW; Fagrell B; Hamsten A; Torffvit O; Jörneskog G
    Diabetes Care; 2003 Sep; 26(9):2575-80. PubMed ID: 12941721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered postural regulation of foot skin oxygenation and blood flow in patients with type 2 diabetes mellitus.
    Iwase M; Imoto H; Murata A; Nakamura U; Nohara S; Uchizono Y; Iino K; Iida M
    Exp Clin Endocrinol Diabetes; 2007 Jul; 115(7):444-7. PubMed ID: 17647142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of medical hyperspectral technology to evaluate microcirculatory changes in diabetic foot ulcers and to predict clinical outcomes.
    Khaodhiar L; Dinh T; Schomacker KT; Panasyuk SV; Freeman JE; Lew R; Vo T; Panasyuk AA; Lima C; Giurini JM; Lyons TE; Veves A
    Diabetes Care; 2007 Apr; 30(4):903-10. PubMed ID: 17303790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xa inhibition and coagulation activity--the influence of prolonged dalteparin treatment and gender in patients with acute coronary syndrome and healthy individuals.
    Oldgren J; Johnston N; Siegbahn A
    Am Heart J; 2008 Mar; 155(3):493.e1-8. PubMed ID: 18294482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the foot elevation the optimal position for wound healing of a diabetic foot?
    Park DJ; Han SK; Kim WK
    J Plast Reconstr Aesthet Surg; 2010 Mar; 63(3):561-4. PubMed ID: 19117825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased transcutaneous oxygen tension in the skin dorsum over the foot in patients with diabetic foot disease in response to the topical use of an emulsion of hyperoxygenated Fatty acids.
    Lázaro-Martínez JL; Sánchez-Ríos JP; García-Morales E; Cecilia-Matilla A; Segovia-Gómez T
    Int J Low Extrem Wounds; 2009 Dec; 8(4):187-93. PubMed ID: 19825855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketanserin in the treatment of diabetic foot ulcer with severe peripheral vascular disease.
    Apelqvist J; Castenfors J; Larsson J; Stenström A; Persson G
    Int Angiol; 1990; 9(2):120-4. PubMed ID: 2254674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic diabetic foot ulcers with bemiparin: a randomized, triple-blind, placebo-controlled, clinical trial.
    Rullan M; Cerdà L; Frontera G; Masmiquel L; Llobera J
    Diabet Med; 2008 Sep; 25(9):1090-5. PubMed ID: 19183313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of polyneuropathy on foot microcirculation in Type II diabetes.
    Nabuurs-Franssen MH; Houben AJ; Tooke JE; Schaper NC
    Diabetologia; 2002 Aug; 45(8):1164-71. PubMed ID: 12189447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of exercise on foot perfusion in diabetes.
    Williams DT; Harding KG; Price PE
    Diabet Med; 2007 Oct; 24(10):1105-11. PubMed ID: 17593240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A descriptive study of skin temperature, tissue perfusion, and tissue oxygen in patients with chronic venous disease.
    Kelechi TJ; Michel Y
    Biol Res Nurs; 2007 Jul; 9(1):70-80. PubMed ID: 17601858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microcirculation disturbances in patients with venous ulcer before and after healing as assessed by laser Doppler flux-metry.
    Mlacak B; Blinc A; Gale N; Ivka B
    Arch Med Res; 2005; 36(5):480-4. PubMed ID: 16099325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy.
    Casellini CM; Barlow PM; Rice AL; Casey M; Simmons K; Pittenger G; Bastyr EJ; Wolka AM; Vinik AI
    Diabetes Care; 2007 Apr; 30(4):896-902. PubMed ID: 17392551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemostatic effects of phytoestrogen genistein in postmenopausal women.
    Trifiletti A; Gaudio A; Lasco A; Atteritano M; Scamardi R; Pizzoleo MA; Morabito N; Frisina N
    Thromb Res; 2008; 123(2):231-5. PubMed ID: 18410952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodialysis is associated with changes in cutaneous microcirculation in diabetes mellitus.
    Beckert S; Sundermann K; Wolf S; Königsrainer A; Coerper S
    Diabet Med; 2009 Jan; 26(1):89-92. PubMed ID: 19125767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia.
    Powell RJ; Simons M; Mendelsohn FO; Daniel G; Henry TD; Koga M; Morishita R; Annex BH
    Circulation; 2008 Jul; 118(1):58-65. PubMed ID: 18559703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.